Common Stock, Shares, Outstanding of ImmunityBio, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ImmunityBio, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • ImmunityBio, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 1,011,800,008, a 19% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ImmunityBio, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,011,800,008 +158,895,668 +19% 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q3 2025 984,965,179 +288,133,883 +41% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 915,625,053 +223,831,884 +32% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 853,556,193 +176,552,782 +26% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 852,904,340 +182,036,996 +27% 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q3 2024 696,831,296 +29,128,256 +4.4% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 691,793,169 +251,119,272 +57% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 677,003,411 +255,434,296 +61% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 670,867,344 +249,298,229 +59% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 667,703,040 +267,398,934 +67% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 440,673,897 +42,604,131 +11% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 421,569,115 +23,612,353 +5.9% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 421,569,115 +23,739,071 +6% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 400,304,106 +5,794,411 +1.5% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 398,069,766 +7,722,026 +2% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 397,956,762 +14,889,441 +3.9% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 397,830,044 +15,586,902 +4.1% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 394,509,695 +285,917,112 +263% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 390,347,740 +282,583,582 +262% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 383,067,321 +284,568,889 +289% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 382,243,142 +10,266,147 +2.8% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 108,592,583 +10,225,399 +10% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 107,764,158 +9,456,299 +9.6% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 98,498,432 -175,721 -0.18% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 371,976,995 +292,889,261 +370% 31 Dec 2019 8-K/A 22 Apr 2021
Q3 2019 98,367,184 +19,141,101 +24% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 98,307,859 +19,142,040 +24% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 98,674,153 +19,585,953 +25% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 79,087,734 +65,856 +0.08% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q3 2018 79,226,083 -214,617 -0.27% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 79,165,819 -264,881 -0.33% 30 Jun 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 79,088,200 -3,067,662 -3.7% 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 79,021,878 -2,962,059 -3.6% 31 Dec 2017 10-K 13 Mar 2019 2018 FY
Q3 2017 79,440,700 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 79,430,700 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 82,155,862 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 81,983,937 +672,251 +0.83% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q4 2015 81,311,686 31 Dec 2015 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.